(2E,11α,13E,15S,17R)-11,15-Dihydroxy-17,20-diMethyl- 9-옥소프로스타-2,13-디엔-1-오산

기본 정보

• 표준명: (2E,11α,13E,15S,17R)-11,15-Dihydroxy-17,20-diMethyl- 9-옥소프로스타-2,13-디엔-1-오산
• CAS 레지스트리 번호: 75554-85-7
• 분자식: C22H36O5
• 분자 무게: 380.525
• Mol 파일: 75554-85-7.mol

동의어: (2E)-7-[(1R,2R,3R)-3-hydroxy-2-[(1E,3S,5R)-3-hydroxy-5-Methyl-1-nonenyl]-5-oxocyclopentyl]-2-heptenoic Acid;(2E,11α,13E,15S,17R)-11,15-Dihydroxy-17,20-diMethyl-
9-옥소프로스타-2,13-디엔-1-오산;17epi-LiMaprost

관련 CAS 번호: 75803-36-0 79786-98-4 78410-93-2 754121-78-3 73927-12-5 7771-58-6 71519-98-7 712353-87-2 766-95-0 7497-11-2

표준명의 화학적 성질

물리적 데이터:

안전정보:

• 픽토그램:
• 위험 코드:
• 진술:
• 안전 선언문:

사용:

• 소개 및 적용: (2E,11α,13E,15S,17R)-11,15-Dihydroxy-17,20-dimethyl-9-oxoprosta-2,13-dien-1-oic acid, also known as 17epi-Limaprost, is an impurity found in Limaprost (L461500). It is used in the pharmaceutical industry as an active pharmaceutical ingredient (API) in the synthesis of various drugs, particularly those used for the treatment of glaucoma and other ocular disorders. The use of 17epi-Limaprost is strictly regulated and controlled to ensure the safety and efficacy of the final drug product. It is important to follow the recommended dosage and administration guidelines when using this compound in order to minimize the risk of adverse effects and maximize its therapeutic benefits.